로딩 중…
지수 로딩 중…
JW SHINYAK CORPORATION
067290· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,335+13.08%
2026-06-19
Price Chart
JW SHINYAK CORPORATION+45.03%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 130.85B KRW |
| Revenue | 82.77B KRW |
| Net Income | 2.05B KRW |
| Total Assets | 62.82B KRW |
| Net Assets | 42.88B KRW |
| Employees | 188 |
| Value | |
| P/E | 63.91x |
| P/B | 3.05x |
| P/S | 1.58x |
| EV/EBITDA | 36.31x |
| FCF Yield | 3.39% |
| Profitability | |
| ROE | 4.77% |
| ROA | 3.26% |
| Op. Margin | 4.40% |
| Revenue Growth | 8.77% |
| Earnings Growth | -68.71% |
| Financial Health | |
| Debt Ratio | 146.49% |
| Total Debt | 1.50B KRW |
| FCF | 4.44B KRW |
| Cash | 191.4M KRW |
| Current Ratio | 1.72x |
| Net Debt/EBITDA | 0.36x |
| Dividend | |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 45.03% |
| 1M Return | 47.97% |
| From 52W High | -12.55% |
| 1Y MDD | -49.44% |
| Trading | |
| Volume | 63,073,185 shares |
| Foreign Own. | 2.18% |
| Per Share | |
| EPS | 175 KRW |
| BPS | 767 KRW |
Company Info
Established in 1975, the company was listed on KOSDAQ in 2003 and rebranded as JW Shin Yak in 2016 after absorbing the former Joongwae Shin Yak in 2009. It manufactures and sells specialized pharmaceuticals, including antifungals and urological agents, serving the dermatology, urology, pediatrics, and internal medicine markets. JW Shin Yak is developing CAR-NK therapies using macrophage gene manipulation technology to enter the next-generation anti-cancer market and expand into the hair loss and cosmeceutical sectors. The company is headquartered in Gwacheon, Gyeonggi Province.